Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Inferior Vena Caval Thrombosis

  • Author: Luis G Fernandez, MD, FACS, FASAS, FCCP, FCCM, FICS, KHS; Chief Editor: John Geibel, MD, DSc, MSc, MA  more...
 
Updated: Dec 01, 2015
 

Background

Thrombosis of the inferior vena cava (IVC) is an underrecognized entity with a variety of clinical presentations. The general concepts of deep venous thrombosis (DVT) and thrombophlebitis are discussed in detail in Deep Venous Thrombosis. However, the implications and complexity of inferior vena caval thrombosis (IVCT) merit specific attention.

From a global standpoint, IVCT represents a subset of DVT. Virchow recognized and described the factors predisposing a patient to venous thrombosis. The triad of stasis, vessel injury, and hypercoagulability formulated by Virchow remain the foundation for our understanding of the pathophysiology of DVT in general and for IVCT in particular (see the image below).

Virchow triad/venous thromboembolism (VTE) risk fa Virchow triad/venous thromboembolism (VTE) risk factors.

As appreciation of the impact of these factors on the patient has improved, therapy has become more directed.

Quick guide

The clinical presentation of inferior vena caval thrombosis varies, depending on extent and location of the thrombus. Because of the variability in signs and symptoms, using a classification system to describe the clinical features may aid in the diagnosis of inferior vena caval thrombosis.

Thrombophilic screening and evaluation of the clotting and fibrinolytic systems may aid in the diagnosis of this condition. Contrast venography remains the criterion standard as the optimal diagnostic study for inferior vena caval thrombosis.

Medical management of vena caval thrombosis focuses on anticoagulation and thrombolytic therapy. Surgical management of this condition consists of caval interruption, thrombectomy, or endovascular interventions.

Patient education

For patient education information, see the Circulatory Problems Center, as well as Deep Vein Thrombosis (Blood Clot in the Leg, DVT).

Next

Anatomy

Understanding the anatomy of the inferior vena cava (IVC) and its tributaries is essential to understanding the variability in the clinical presentations of patients with inferior vena caval thrombosis (IVCT) (see the image below).

Veins of abdomen and thorax. Unless stated otherwi Veins of abdomen and thorax. Unless stated otherwise, lithograph plate is from Gray's Anatomy (online edition of the 20th US edition of Gray's Anatomy of the Human Body, originally published in 1918).

The IVC is formed by the confluence of the left and right common iliac veins. Numerous paired segmental lumbar veins drain into the IVC throughout its length. The right gonadal vein empties directly into the cava, while the left gonadal vein generally empties into the left renal vein. The azygous system has connections with the IVC or the renal veins at the level of the renal veins.

The next major veins encountered are the renal veins, followed by the hepatic veins. No valves are within the IVC. The cava enters the thoracic cavity through the tendinous portion of the diaphragm and terminates at its junction with the right atrium.

Several congenital anomalies of venous anatomy can involve the IVC, and their presence can increase the likelihood of IVCT. The symptomatology related to IVCT follows directly from the anatomic location of the thrombus and the degree of the lumen occupied by the thrombus.

Previous
Next

Etiology

To a large degree, the etiology of IVCT mirrors that of DVT in general. However, specific situations relate to the IVC only, but the wide variety of these situations all relate in one or more ways to Virchow's classic description.

Tumors

Numerous malignancies have been associated with IVCT.[1] Perhaps the most familiar is renal cell carcinoma. The intravascular tumor extends from the renal vein and can propagate as far as the heart. It can partially or completely occlude the IVC. Not all intravascular irregularities of the kidney represent tumor thrombus. In one case report, a patient who underwent radical nephrectomy for presumed renal cell carcinoma was subsequently found to have only renal vein thrombosis.[2] Other genitourinary tumors that reportedly cause IVCT are seminomas and teratomas.

Numerous other less common tumors reportedly involve the IVC. Intuitively, any structure that is anatomically related to the IVC can generate either direct compression or vascular invasion. Retroperitoneal leiomyosarcoma,[3] adrenal cortical carcinoma,[4] and renal angiomyolipoma[5] have all presented in association with IVCT. Even hepatic hemangioma has caused IVCT from extrinsic compression.[6] Additionally, malignancy itself is a risk factor for DVT and thus represents a risk factor for the extension of DVT into the IVC.

Compression

Extrinsic compression may also result from nontumoral sources and increase the likelihood of IVCT. The distortion of the normal caval anatomy generates both venous stasis and turbulent flow. This situation facilitates the formation of a thrombus. An activity as innocuous as bicycle riding has reportedly caused IVCT.[7] The spectrum of medical diagnoses that can cause compression of the IVC is determined by those structures anatomically adjacent to the IVC.

Abdominal aortic aneurysms (AAAs) can compress the IVC and cause thrombosis. Although this clinical situation is uncommon, the implications for surgical repair of the aneurysm are significant. The surgeon must be prepared for enlarged venous collaterals and the possibility of unusual tissue-plane configurations. One reported case described incorporation of the IVC into the aneurysm[8] ; the wall of the IVC was actually part of the wall of the aneurysm. Knowing that AAA is a risk factor for IVCT should heighten clinical suspicion in appropriate cases.

Hepatic abscesses, either from amebae or echinococci, can also generate thrombosis of the IVC from compression. Because of the propensity of these processes to evolve over time, patients may present without symptoms suggestive of IVC occlusion. They may only demonstrate evidence of the primary process or of collateral venous hypertrophy. The initial presenting symptom may even be pulmonary embolization.

Other retroperitoneal organ systems that have been shown to cause IVCT include the pancreas and the kidneys. Polycystic disease of the right kidney has reportedly been clinically associated with thrombosis of the IVC.[9] Pancreatic pseudocysts have been observed to cause thrombosis of the IVC.[10] Acute pancreatitis has also been found to generate thrombosis of the IVC.[11, 12]

The pathophysiology of the evolution of the thrombosis may reflect either the local impact of inflammation of the pancreatic head or the impact of a hypercoagulable state on the IVC. Although IVCT in the setting of pancreatitis is uncommon, this clinical entity may account for an unexplained deterioration in the status of a patient with acute pancreatitis.

Hematoma/trauma

Other aspects of compression can be attributed to the presence of a hematoma adjacent to the cava or the iliac systems. Psoas hematomas and other hematomas of the retroperitoneum have been identified as causing IVCT. In one case, the hematoma was the result of a common iliac artery injury. Because the venous system was not involved, the presumed mechanism of compression of the cava by clot seems credible.

Unique among causes, trauma combines the limbs of the Virchow triad. Stasis, vessel injury, and hypercoagulability may all exist in the same clinical situation. Direct trauma to the IVC may be the result of either penetrating or blunt trauma.[13, 14, 15] In the absence of venous laceration, blunt endothelial damage has been postulated to cause IVCT. Other mechanisms observed secondary to trauma include extension of hepatic venous thrombosis and thrombus formation after perihepatic packing.

Dysfunctional coagulation system

By necessity and function, the balance between the coagulation system and the fibrinolytic system is delicate and dynamic. Disorders that disrupt this balance can cause a situation in which IVC thrombus formation may occur.

The nephrotic syndrome is a classic example. Patients with this syndrome have urinary protein losses. Both renal vein thrombosis and IVCT have been described. The exact mechanism of the hypercoagulability of patients with the nephrotic syndrome has not been fully delineated. However, these patients have massive urinary protein loss, and diminished levels of antithrombin III have been observed.

Iatrogenic

Patients with a recent history of medical care may present with iatrogenic IVCT. The expansion of endovascular technology has led to increased recognition of iatrogenic IVCT.[16] Interventions that reportedly have identifiable rates of IVCT include the following:

  • Hepatic transplantation
  • Dialysis access
  • Femoral venous catheters
  • Pacemaker wires
  • Vena caval filters

Awareness of the association of these procedures with IVCT allows clinicians to make educated decisions. Recognizing the association allows an accurate risk-benefit assessment for a given procedure. Additionally, recognizing these factors may aid in determining a prompt diagnosis in patients who have postprocedural clinical changes.

Congenital absence of inferior vena cava

Anomalies of the IVC have been described more frequently (0.6-2%) in those with other cardiovascular defects[17] and less so in otherwise healthy individuals. Various abnormalities of the IVC have been described, including complete absence, partial absence, or presence of bilateral IVC.[18]

Absent IVC is an extremely rare anomaly that is associated with idiopathic DVT, particularly in the young. Controversy exists as to whether an absent IVC has a true embryonic etiology or whether it is the result of perinatal IVC thrombosis causing regression and disappearance of the once present IVC.[19]

A case report has described an absent IVC and left renal hypoplasia and a right hypertrophic kidney.[20] A more commonly recognized association is right renal aplasia, as suggested in a review by Gayer et al, in which all nine patients with complete absence of the IVC had an absent or very small right kidney.[21]

The association of an absent or hypoplastic kidney is related (or may contribute to an absent IVC) to perinatal renal vein thrombosis.[22] Veen et al proposed naming this condition KILT (kidney and IVC abnormalities with leg thromboses) syndrome (when associated with DVT).[20]

It is estimated that DVT occurs 1 case per 1000 patient-years[23] ; in as many as 80% of patients who are affected, a risk factor can be identified. Ruggeri et al presented four cases of absent IVC over a 5-year period that presented with idiopathic DVT in patients younger than 30 years,[24] representing an estimated 5% of cases of idiopathic DVT in young people.

Chee et al similarly noted that as many as 5% of 20- to 40-year-old patients presenting with DVT had an IVC anomaly (four in total, of which three had a complete absence of IVC).[25] This was much higher than the expected 0.5%.

Other associated conditions

Numerous other clinical situations have been associated with IVCT. They may meet some classification criteria to be listed in one or more of the categories mentioned above; however, they are noted here for clarity and can include (1) developmental anomalies of the IVC, (2) retroperitoneal fibrosis, (3) pregnancy, and (4) oral contraceptives.

Although not all-inclusive, the foregoing information provides a review of many of the known clinical situations in which IVCT may be evident. Knowledge of the potential for thrombosis of the IVC increases physicians' level of clinical awareness in patients who present with the identified primary processes.

Previous
Next

Epidemiology

The exact number of patients who have IVCT remains elusive because of the clinical variability in presentation. By compiling information from several epidemiologic studies that investigated DVT prevalence, the following US estimates can be generated:

  • The DVT rate in the United States is 60-180 cases per 100,000 population per year
  • The frequency of IVCT in patients with DVT is 4-15%
  • Annually, 165,000-493,000 cases of DVT occur
  • Between 6,600 and 74,000 cases of IVCT occur each year

These numbers are estimates generated from various population-based studies. Various groups within the general population have a greater propensity for IVCT (see Etiology).

Previous
Next

Prognosis

The outcome of patients with IVCT is often determined by the underlying condition that initially caused the thrombosis. However, some general statements can be made. The impact and outcome of IVCT are as variable as the clinical presentation. In one study, only one third of patients had a correct diagnosis before venography. Adult patients with ligation of their vena cava reportedly have either no symptoms or mild edema after ligation.[26]

A report on children who had IVCT unrelated to catheterization revealed that 50% had persistent IVCT. Symptoms of chronic limb pain and chronic abdominal pain were observed. Another series of pediatric patients with IVCT secondary to central venous access identified no sequelae unless concurrent superior vena cava thrombosis was present. Finally, the outcome of patients who have IVCT relates to the embolic risk associated with DVT overall. If the cava is occluded, pulmonary embolization does not present a significant risk. However, if a caval lumen remains, embolization may occur.

Previous
 
 
Contributor Information and Disclosures
Author

Luis G Fernandez, MD, FACS, FASAS, FCCP, FCCM, FICS, KHS Assistant Clinical Professor of Surgery and Family Practice, University of Texas Health Science Center; Adjunct Clinical Professor of Medicine and Nursing, University of Texas, Arlington; Chairman, Division of Trauma Surgery and Surgical Critical Care, Chief of Trauma Surgical Critical Care Unit, Trinity Mother Francis Health System; Brigadier General, Texas Medical Rangers, TXSG/MB

Luis G Fernandez, MD, FACS, FASAS, FCCP, FCCM, FICS, KHS is a member of the following medical societies: American Association for the Surgery of Trauma, American College of Chest Physicians, American College of Legal Medicine, American College of Surgeons, American Society of Abdominal Surgeons, American Society of Law, Medicine & Ethics, American Trauma Society, Association for Surgical Education, Association of Military Surgeons of the US, Chicago Medical Society, Illinois State Medical Society, International College of Surgeons, New York Academy of Sciences, Society of Critical Care Medicine, Society of Laparoendoscopic Surgeons, Southeastern Surgical Congress, Texas Medical Association, Undersea and Hyperbaric Medical Society, American Society of General Surgeons, American Society of General Surgeons, Pan American Trauma Society

Disclosure: Received honoraria from KCI for speaking and teaching; Partner received honoraria from PACIRA for speaking and teaching. for: Received honoraria from PACIRA for speaking and teaching.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

John Geibel, MD, DSc, MSc, MA Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director, Surgical Research, Department of Surgery, Yale-New Haven Hospital; American Gastroenterological Association Fellow

John Geibel, MD, DSc, MSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, Society for Surgery of the Alimentary Tract

Disclosure: Received royalty from AMGEN for consulting; Received ownership interest from Ardelyx for consulting.

Acknowledgements

Douglas M Geehan, MD Associate Professor, Department of Surgery, University of Missouri-Kansas City School of Medicine

Disclosure: Nothing to disclose.

Michael A Grosso, MD Consulting Staff, Department of Cardiothoracic Surgery, St Francis Hospital

Michael A Grosso, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Society of University Surgeons

Disclosure: Nothing to disclose.

References
  1. Kraft C, Schuettfort G, Weil Y, Tirneci V, Kasper A, Haberichter B, et al. Thrombosis of the inferior vena cava and malignant disease. Thromb Res. 2014 Sep. 134(3):668-73. [Medline].

  2. Takayama H, Kinouchi T, Meguro N, Maeda O, Saiki S, Kuroda M, et al. Renal vein thrombosis misdiagnosed as a renal cell carcinoma with a tumor thrombus in the inferior vena cava. Int J Urol. 1998 Jan. 5(1):94-5. [Medline].

  3. Hartman DS, Hayes WS, Choyke PL, Tibbetts GP. From the archives of the AFIP. Leiomyosarcoma of the retroperitoneum and inferior vena cava: radiologic-pathologic correlation. Radiographics. 1992 Nov. 12(6):1203-20. [Medline].

  4. Figueroa AJ, Stein JP, Lieskovsky G, Skinner DG. Adrenal cortical carcinoma associated with venous tumour thrombus extension. Br J Urol. 1997 Sep. 80(3):397-400. [Medline].

  5. Gotoh A, Gohji K, Fujisawa M, Okada H, Arakawa S, Hanioka K, et al. Renal angiomyolipoma associated with inferior vena caval tumour thrombus. Br J Urol. 1998 May. 81(5):773-4. [Medline].

  6. Paolillo V, Sicuro M, Nejrotti A, Rizzetto M, Casaccia M. Pulmonary embolism due to compression of the inferior vena cava by a hepatic hemangioma. Tex Heart Inst J. 1993. 20(1):66-8. [Medline]. [Full Text].

  7. Simpson AH, Kilby JO. Inferior vena cava thrombosis following a cycle ride. J R Soc Med. 1988 Dec. 81(12):738-9. [Medline]. [Full Text].

  8. Flynn P, Zammit-Maempel I. Case report: computed tomography demonstration of inferior vena caval thrombosis and incorporation into an abdominal aortic aneurysm. Clin Radiol. 1998 Apr. 53(4):306-7. [Medline].

  9. O'Sullivan DA, Torres VE, Heit JA, Liggett S, King BF. Compression of the inferior vena cava by right renal cysts: an unusual cause of IVC and/or iliofemoral thrombosis with pulmonary embolism in autosomal dominant polycystic kidney disease. Clin Nephrol. 1998 May. 49(5):332-4. [Medline].

  10. Peillon C, Manouvrier JL, Testart J. Inferior vena cava thrombosis secondary to chronic pancreatitis with pseudocyst. Am J Gastroenterol. 1991 Dec. 86(12):1854-6. [Medline].

  11. Jones AL, Ojar D, Redhead D, Proudfoot AT. Case report: Use of an IVC filter in the management of IVC thrombosis occurring as a complication of acute pancreatitis. Clin Radiol. 1998 Jun. 53(6):462-4. [Medline].

  12. Stringer MD, Michell M, McIrvine AJ. Inferior vena caval thrombosis complicating acute pancreatitis. Case report. Acta Chir Scand. 1988 Feb. 154(2):161-3. [Medline].

  13. Campbell DN, Liechty RD, Rutherford RB. Traumatic thrombosis of the inferior vena cava. J Trauma. 1981 May. 21(5):413-5. [Medline].

  14. Nagy KK, Duarte B. Post-traumatic inferior vena caval thrombosis: case report. J Trauma. 1990 Feb. 30(2):218-21. [Medline].

  15. Takeuchi M, Maruyama K, Nakamura M, Chikusa H, Yoshida T, Muneyuki M, et al. Posttraumatic inferior vena caval thrombosis: case report and review of the literature. J Trauma. 1995 Sep. 39(3):605-8. [Medline].

  16. Peck KE, Bonoan JT, Cunha BA. Postlaparoscopic traumatic inferior vena caval thrombosis. Heart Lung. 1998 Jul-Aug. 27(4):279-82. [Medline].

  17. ANDERSON RC, ADAMS P Jr, BURKE B. Anomalous inferior vena cava with azygos continuation (infrahepatic interruption of the inferior vena cava). Report of 15 new cases. J Pediatr. 1961 Sep. 59:370-83. [Medline].

  18. Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH Jr. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000 May-Jun. 20(3):639-52. [Medline].

  19. Ramanathan T, Hughes TM, Richardson AJ. Perinatal inferior vena cava thrombosis and absence of the infrarenal inferior vena cava. J Vasc Surg. 2001 May. 33(5):1097-9. [Medline].

  20. Van Veen J, Hampton KK, Makris M. Kilt syndrome?. Br J Haematol. 2002 Sep. 118(4):1199-200. [Medline].

  21. Gayer G, Zissin R, Strauss S, Hertz M. IVC anomalies and right renal aplasia detected on CT: a possible link?. Abdom Imaging. 2003 May-Jun. 28(3):395-9. [Medline].

  22. Dougherty MJ, Calligaro KD, DeLaurentis DA. Congenitally absent inferior vena cava presenting in adulthood with venous stasis and ulceration: a surgically treated case. J Vasc Surg. 1996 Jan. 23(1):141-6. [Medline].

  23. White RH. The epidemiology of venous thromboembolism. Circulation. 2003 Jun 17. 107(23 Suppl 1):I4-8. [Medline].

  24. Ruggeri M, Tosetto A, Castaman G, Rodeghiero F. Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis. Lancet. 2001 Feb 10. 357(9254):441. [Medline].

  25. Chee YL, Culligan DJ, Watson HG. Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young. Br J Haematol. 2001 Sep. 114(4):878-80. [Medline].

  26. Perhoniemi V, Salmenkivi K, Vorne M. Venous haemodynamics in the legs after ligation of the inferior vena cava. Acta Chir Scand. 1986 Jan. 152:23-7. [Medline].

  27. Koc Z, Oguzkurt L. Interruption or congenital stenosis of the inferior vena cava: prevalence, imaging, and clinical findings. Eur J Radiol. 2007 May. 62(2):257-66. [Medline].

  28. Ueda J, Hara K, Kobayashi Y, Ohue S, Uchida H. Anomaly of the inferior vena cava observed by CT. Comput Radiol. 1983 May-Jun. 7(3):145-54. [Medline].

  29. Gayer G, Luboshitz J, Hertz M, Zissin R, Thaler M, Lubetsky A, et al. Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis. AJR Am J Roentgenol. 2003 Mar. 180(3):729-32. [Medline].

  30. Cho BC, Choi HJ, Kang SM, Chang J, Lee SM, Yang DG, et al. Congenital absence of inferior vena cava as a rare cause of pulmonary thromboembolism. Yonsei Med J. 2004 Oct 31. 45(5):947-51. [Medline].

  31. D'Aloia A, Faggiano P, Fiorina C, Vizzardi E, Bontempi L, Grazioli L, et al. Absence of inferior vena cava as a rare cause of deep venous thrombosis complicated by liver and lung embolism. Int J Cardiol. 2003 Apr. 88(2-3):327-9. [Medline].

  32. Takehara N, Hasebe N, Enomoto S, Takeuchi T, Takahashi F, Ota T, et al. Multiple and recurrent systemic thrombotic events associated with congenital anomaly of inferior vena cava. J Thromb Thrombolysis. 2005 Apr. 19(2):101-3. [Medline].

  33. Iqbal J, Nagaraju E. Congenital absence of inferior vena cava and thrombosis: a case report. J Med Case Reports. 2008 Feb 12. 2:46. [Medline]. [Full Text].

  34. Lei F, Li X, Qian A, Yu X, Rong J, Sang H, et al. [Therapy of catheter-directed thrombolysis for inferior vena cava thrombosis after filter implantation]. Zhonghua Yi Xue Za Zhi. 2014 Jul 22. 94(28):2197-200. [Medline].

 
Previous
Next
 
Virchow triad/venous thromboembolism (VTE) risk factors.
Photo showing dilated superficial abdominal veins (upper quadrant), with bruising and thrombosed large abdominal veins (lower quadrant).
Abdominal CT scan shows absent inferior vena cava with thrombosis of very prominent collateral veins in the abdominal wall, corresponding to right side of abdomen as seen in earlier photo.
Veins of abdomen and thorax. Unless stated otherwise, lithograph plate is from Gray's Anatomy (online edition of the 20th US edition of Gray's Anatomy of the Human Body, originally published in 1918).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.